CelLBxHealth plc (AIM:CLBX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.8330
-0.0420 (-4.80%)
Sep 25, 2026, 4:07 PM GMT

CelLBxHealth Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, CelLBxHealth stock has a consensus rating of "Strong Buy" and an average price target of 3p. The average 1-year stock price forecast is 260.14% higher than the current stock price, while the lowest is 2p (+140.10%) and the highest is 4p (+380.19%).

Price Target: 3p (+260.14%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price2p3p3p4p
Change+140.10%+260.14%+260.14%+380.19%

Analyst Ratings

The average analyst rating for CelLBxHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy001112
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total001112

Financial Forecast

Revenue This Year
15.13M
from 1.35M
Increased by 1,020.16%
Revenue Next Year
27.03M
from 15.13M
Increased by 78.63%
EPS This Year
-0.02
from -0.04
EPS Next Year
-0.00
from -0.02
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.01M1.04M2.19M2.86M1.35M15.13M
Revenue Growth
32.94%2.76%109.99%30.92%-52.80%1,020.16%
Operating Income
-16.73M-25.49M-19.82M-14.96M-14.74M-6.73M
Net Income
-15.01M-21.69M-20.13M-14.23M-19.51M-8.55M
EPS
-----0.04-0.02
Free Cash Flow
-----9.48M-5.61M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.

Revenue Forecast

Revenue202620272028
High41.2M
Avg15.1M
Low2.1M

Revenue Growth

Revenue Growth202620272028
High
2,949.6%
Avg
1,020.2%
Low
55.4%

EPS Forecast

EPS202620272028
High-0.00
Avg-0.02
Low-0.04

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-